Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial.

Valcyte (valganciclovir) - Roche, Tanabe Pharma

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42639594

Barbara Haber; Christopher L Gilbert; Flavio Vincenti; M Hong Nguyen; Natalya Broyde; Oliver Witzke; Stefan Schneeberger; Suphamai Bunnapradist

Aug 26, 2026